Neurogene Ownership 2024 | Who Owns Neurogene Now?
Institutional Ownership
31.40%
Insider Ownership
16.46%
Retail Ownership
52.14%
Institutional Holders
37.00
Neurogene Institutional Shareholders
Institutional Shareholders by % of Total Shares
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
US BANCORP \DE\ | - | - | - | -44,346 | -100.00% | - | Sep 30, 2023 |
WELLS FARGO & COMPANY/MN | - | - | - | -8,244 | -100.00% | - | Sep 30, 2023 |
NORTHERN TRUST CORP | - | - | - | -69,541 | -100.00% | - | Sep 30, 2023 |
MORGAN STANLEY | - | - | - | -821,972 | -100.00% | - | Sep 30, 2023 |
NATIONAL BANK OF CANADA /FI/ | - | - | - | -175 | -100.00% | - | Sep 30, 2023 |
GROUP ONE TRADING, L.P. | - | - | - | -1,504 | -100.00% | - | Sep 30, 2023 |
FEDERATED HERMES, INC. | - | - | - | -1,555 | -100.00% | - | Sep 30, 2023 |
TWO SIGMA INVESTMENTS, LP | - | - | - | -211,194 | -100.00% | - | Sep 30, 2023 |
GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -301,057 | -100.00% | - | Sep 30, 2023 |
BAKER BROS. ADVISORS LP | - | - | - | -3,821,740 | -100.00% | - | Sep 30, 2023 |
BLACKROCK INC. | - | - | - | -483,948 | -100.00% | - | Sep 30, 2023 |
BANK OF NEW YORK MELLON CORP | - | - | - | -14,372 | -100.00% | - | Sep 30, 2023 |
HIGHTOWER ADVISORS, LLC | - | - | - | -48,409 | -100.00% | - | Sep 30, 2023 |
TWO SIGMA ADVISERS, LP | - | - | - | -184,500 | -100.00% | - | Sep 30, 2023 |
POINT72 ASSET MANAGEMENT, L.P. | - | - | - | -136,675 | -100.00% | - | Sep 30, 2023 |
UBS GROUP AG | - | - | - | -1,100 | -100.00% | - | Sep 30, 2023 |
BML CAPITAL MANAGEMENT, LLC | - | - | - | -23,749 | -100.00% | - | Sep 30, 2023 |
ALTA FUNDAMENTAL ADVISERS LLC | - | - | - | -89,702 | -100.00% | - | Sep 30, 2023 |
ADVISOR GROUP HOLDINGS, INC. | - | - | - | -1,500 | -100.00% | - | Sep 30, 2023 |
SIMON QUICK ADVISORS, LLC | - | - | - | -23,428 | -100.00% | - | Sep 30, 2023 |
Neurogene's largest institutional shareholder is US BANCORP \DE\, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.
Institutional Shareholders by % of Total Assets
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
US BANCORP \DE\ | - | - | - | -44,346 | -100.00% | - | Sep 30, 2023 |
WELLS FARGO & COMPANY/MN | - | - | - | -8,244 | -100.00% | - | Sep 30, 2023 |
NORTHERN TRUST CORP | - | - | - | -69,541 | -100.00% | - | Sep 30, 2023 |
MORGAN STANLEY | - | - | - | -821,972 | -100.00% | - | Sep 30, 2023 |
NATIONAL BANK OF CANADA /FI/ | - | - | - | -175 | -100.00% | - | Sep 30, 2023 |
GROUP ONE TRADING, L.P. | - | - | - | -1,504 | -100.00% | - | Sep 30, 2023 |
FEDERATED HERMES, INC. | - | - | - | -1,555 | -100.00% | - | Sep 30, 2023 |
TWO SIGMA INVESTMENTS, LP | - | - | - | -211,194 | -100.00% | - | Sep 30, 2023 |
GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -301,057 | -100.00% | - | Sep 30, 2023 |
BAKER BROS. ADVISORS LP | - | - | - | -3,821,740 | -100.00% | - | Sep 30, 2023 |
BLACKROCK INC. | - | - | - | -483,948 | -100.00% | - | Sep 30, 2023 |
BANK OF NEW YORK MELLON CORP | - | - | - | -14,372 | -100.00% | - | Sep 30, 2023 |
HIGHTOWER ADVISORS, LLC | - | - | - | -48,409 | -100.00% | - | Sep 30, 2023 |
TWO SIGMA ADVISERS, LP | - | - | - | -184,500 | -100.00% | - | Sep 30, 2023 |
POINT72 ASSET MANAGEMENT, L.P. | - | - | - | -136,675 | -100.00% | - | Sep 30, 2023 |
UBS GROUP AG | - | - | - | -1,100 | -100.00% | - | Sep 30, 2023 |
BML CAPITAL MANAGEMENT, LLC | - | - | - | -23,749 | -100.00% | - | Sep 30, 2023 |
ALTA FUNDAMENTAL ADVISERS LLC | - | - | - | -89,702 | -100.00% | - | Sep 30, 2023 |
ADVISOR GROUP HOLDINGS, INC. | - | - | - | -1,500 | -100.00% | - | Sep 30, 2023 |
SIMON QUICK ADVISORS, LLC | - | - | - | -23,428 | -100.00% | - | Sep 30, 2023 |
The largest Neurogene shareholder by % of total assets is US BANCORP \DE\. The company owns 0.00 shares of Neurogene (NLTX), representing 0.00% of its total assets.
Institutional Buyers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
NATIONAL BANK OF CANADA /FI/ | - | - | - | -175 | -100.00% | - | Sep 30, 2023 |
TRUVESTMENTS CAPITAL LLC | - | - | - | -925 | -100.00% | - | Sep 30, 2023 |
- | - | - | -1,000 | -100.00% | - | Sep 30, 2023 | |
UBS GROUP AG | - | - | - | -1,100 | -100.00% | - | Sep 30, 2023 |
ADVISOR GROUP HOLDINGS, INC. | - | - | - | -1,500 | -100.00% | - | Sep 30, 2023 |
GROUP ONE TRADING, L.P. | - | - | - | -1,504 | -100.00% | - | Sep 30, 2023 |
FEDERATED HERMES, INC. | - | - | - | -1,555 | -100.00% | - | Sep 30, 2023 |
WELLS FARGO & COMPANY/MN | - | - | - | -8,244 | -100.00% | - | Sep 30, 2023 |
BANK OF NEW YORK MELLON CORP | - | - | - | -14,372 | -100.00% | - | Sep 30, 2023 |
SIMON QUICK ADVISORS, LLC | - | - | - | -23,428 | -100.00% | - | Sep 30, 2023 |
BML CAPITAL MANAGEMENT, LLC | - | - | - | -23,749 | -100.00% | - | Sep 30, 2023 |
US BANCORP \DE\ | - | - | - | -44,346 | -100.00% | - | Sep 30, 2023 |
HIGHTOWER ADVISORS, LLC | - | - | - | -48,409 | -100.00% | - | Sep 30, 2023 |
NORTHERN TRUST CORP | - | - | - | -69,541 | -100.00% | - | Sep 30, 2023 |
ALTA FUNDAMENTAL ADVISERS LLC | - | - | - | -89,702 | -100.00% | - | Sep 30, 2023 |
PRIVIUM FUND MANAGEMENT (UK) LTD | - | - | - | -117,200 | -100.00% | - | Sep 30, 2023 |
PRIVIUM FUND MANAGEMENT B.V. | - | - | - | -117,200 | -100.00% | - | Sep 30, 2023 |
POINT72 ASSET MANAGEMENT, L.P. | - | - | - | -136,675 | -100.00% | - | Sep 30, 2023 |
TWO SIGMA ADVISERS, LP | - | - | - | -184,500 | -100.00% | - | Sep 30, 2023 |
TWO SIGMA INVESTMENTS, LP | - | - | - | -211,194 | -100.00% | - | Sep 30, 2023 |
As of Sep 30 2023, Neurogene's largest institutional buyer is NATIONAL BANK OF CANADA /FI/. The company purchased -0.17K stocks of NLTX, valued at -.
Institutional Sellers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
BAKER BROS. ADVISORS LP | - | - | - | -3,821,740 | -100.00% | - | Sep 30, 2023 |
LYNX1 CAPITAL MANAGEMENT LP | - | - | - | -3,094,554 | -100.00% | - | Sep 30, 2023 |
MORGAN STANLEY | - | - | - | -821,972 | -100.00% | - | Sep 30, 2023 |
BLACKROCK INC. | - | - | - | -483,948 | -100.00% | - | Sep 30, 2023 |
GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -301,057 | -100.00% | - | Sep 30, 2023 |
TWO SIGMA INVESTMENTS, LP | - | - | - | -211,194 | -100.00% | - | Sep 30, 2023 |
TWO SIGMA ADVISERS, LP | - | - | - | -184,500 | -100.00% | - | Sep 30, 2023 |
POINT72 ASSET MANAGEMENT, L.P. | - | - | - | -136,675 | -100.00% | - | Sep 30, 2023 |
PRIVIUM FUND MANAGEMENT B.V. | - | - | - | -117,200 | -100.00% | - | Sep 30, 2023 |
PRIVIUM FUND MANAGEMENT (UK) LTD | - | - | - | -117,200 | -100.00% | - | Sep 30, 2023 |
ALTA FUNDAMENTAL ADVISERS LLC | - | - | - | -89,702 | -100.00% | - | Sep 30, 2023 |
NORTHERN TRUST CORP | - | - | - | -69,541 | -100.00% | - | Sep 30, 2023 |
HIGHTOWER ADVISORS, LLC | - | - | - | -48,409 | -100.00% | - | Sep 30, 2023 |
US BANCORP \DE\ | - | - | - | -44,346 | -100.00% | - | Sep 30, 2023 |
BML CAPITAL MANAGEMENT, LLC | - | - | - | -23,749 | -100.00% | - | Sep 30, 2023 |
SIMON QUICK ADVISORS, LLC | - | - | - | -23,428 | -100.00% | - | Sep 30, 2023 |
BANK OF NEW YORK MELLON CORP | - | - | - | -14,372 | -100.00% | - | Sep 30, 2023 |
WELLS FARGO & COMPANY/MN | - | - | - | -8,244 | -100.00% | - | Sep 30, 2023 |
FEDERATED HERMES, INC. | - | - | - | -1,555 | -100.00% | - | Sep 30, 2023 |
GROUP ONE TRADING, L.P. | - | - | - | -1,504 | -100.00% | - | Sep 30, 2023 |
As of Sep 30 2023, Neurogene's biggest institutional seller is BAKER BROS. ADVISORS LP. The company sold -3.82M shares of NLTX, valued at -.
Institutional New positions
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|
Institutional Sold Out
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
BAKER BROS. ADVISORS LP | - | - | - | -3,821,740 | -100.00% | - | Sep 30, 2023 |
LYNX1 CAPITAL MANAGEMENT LP | - | - | - | -3,094,554 | -100.00% | - | Sep 30, 2023 |
MORGAN STANLEY | - | - | - | -821,972 | -100.00% | - | Sep 30, 2023 |
BLACKROCK INC. | - | - | - | -483,948 | -100.00% | - | Sep 30, 2023 |
GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -301,057 | -100.00% | - | Sep 30, 2023 |
TWO SIGMA INVESTMENTS, LP | - | - | - | -211,194 | -100.00% | - | Sep 30, 2023 |
TWO SIGMA ADVISERS, LP | - | - | - | -184,500 | -100.00% | - | Sep 30, 2023 |
POINT72 ASSET MANAGEMENT, L.P. | - | - | - | -136,675 | -100.00% | - | Sep 30, 2023 |
PRIVIUM FUND MANAGEMENT B.V. | - | - | - | -117,200 | -100.00% | - | Sep 30, 2023 |
PRIVIUM FUND MANAGEMENT (UK) LTD | - | - | - | -117,200 | -100.00% | - | Sep 30, 2023 |
ALTA FUNDAMENTAL ADVISERS LLC | - | - | - | -89,702 | -100.00% | - | Sep 30, 2023 |
NORTHERN TRUST CORP | - | - | - | -69,541 | -100.00% | - | Sep 30, 2023 |
HIGHTOWER ADVISORS, LLC | - | - | - | -48,409 | -100.00% | - | Sep 30, 2023 |
US BANCORP \DE\ | - | - | - | -44,346 | -100.00% | - | Sep 30, 2023 |
BML CAPITAL MANAGEMENT, LLC | - | - | - | -23,749 | -100.00% | - | Sep 30, 2023 |
SIMON QUICK ADVISORS, LLC | - | - | - | -23,428 | -100.00% | - | Sep 30, 2023 |
BANK OF NEW YORK MELLON CORP | - | - | - | -14,372 | -100.00% | - | Sep 30, 2023 |
WELLS FARGO & COMPANY/MN | - | - | - | -8,244 | -100.00% | - | Sep 30, 2023 |
FEDERATED HERMES, INC. | - | - | - | -1,555 | -100.00% | - | Sep 30, 2023 |
GROUP ONE TRADING, L.P. | - | - | - | -1,504 | -100.00% | - | Sep 30, 2023 |
ADVISOR GROUP HOLDINGS, INC. | - | - | - | -1,500 | -100.00% | - | Sep 30, 2023 |
UBS GROUP AG | - | - | - | -1,100 | -100.00% | - | Sep 30, 2023 |
- | - | - | -1,000 | -100.00% | - | Sep 30, 2023 | |
TRUVESTMENTS CAPITAL LLC | - | - | - | -925 | -100.00% | - | Sep 30, 2023 |
NATIONAL BANK OF CANADA /FI/ | - | - | - | -175 | -100.00% | - | Sep 30, 2023 |
Neurogene's largest sold out institutional shareholder by shares sold is BAKER BROS. ADVISORS LP, sold -3.82M shares, valued at -, as of undefined.
Neurogene Mutual Fund Holders
Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
---|---|---|---|---|---|
ROYCE MICRO-CAP TRUST, INC. | 0.30% | 145,397 | - | - | Mar 31, 2024 |
BRIDGEWAY FUNDS INC | 0.03% | 75,000 | - | - | Mar 28, 2024 |
VANGUARD VALLEY FORGE FUNDS | 0.01% | 5,484 | - | - | Mar 31, 2024 |
DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 5,089 | - | - | Mar 31, 2024 |
QUANTITATIVE MASTER SERIES LLC | 0.01% | 49,979 | - | - | Mar 31, 2024 |
TIAA SEPARATE ACCOUNT VA 1 | 0.01% | 1,362 | - | - | Mar 31, 2024 |
Humankind Benefit Corp | 0.00% | 107 | - | - | Dec 31, 2023 |
Destra Investment Trust | 0.00% | 4,686 | - | - | Mar 31, 2024 |
VANGUARD INDEX FUNDS | 0.00% | 972,378 | - | - | Mar 31, 2024 |
SCHWAB CAPITAL TRUST | 0.00% | 88,594 | - | - | Feb 29, 2024 |
GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.00% | 6,006 | - | - | Mar 31, 2024 |
FIDELITY COMMONWEALTH TRUST | 0.00% | 4,418 | - | - | Feb 29, 2024 |
FIDELITY CONCORD STREET TRUST | 0.00% | 279,557 | - | - | Feb 29, 2024 |
TIAA-CREF LIFE FUNDS | 0.00% | 3,023 | - | - | Mar 31, 2024 |
Calvert Variable Products, Inc. | 0.00% | 2,623 | - | - | Mar 31, 2024 |
FIDELITY COVINGTON TRUST | 0.00% | 15,936 | - | - | Jan 31, 2024 |
VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 24,542 | - | - | Mar 31, 2024 |
Meeder Funds | 0.00% | 3,757 | - | - | Mar 31, 2024 |
Trust for Advised Portfolios | 0.00% | 15,219 | - | - | Dec 31, 2023 |
NATIONWIDE MUTUAL FUNDS | 0.00% | 90,100 | - | - | Jan 31, 2024 |
SunAmerica Specialty Series | 0.00% | 266 | - | - | Apr 30, 2021 |
VANGUARD INDEX FUNDS | 0.00% | 194,475 | - | - | Mar 31, 2024 |
OHIO NATIONAL FUND INC | 0.00% | 9,004 | - | - | Mar 31, 2024 |
Voya VARIABLE PORTFOLIOS INC | 0.00% | 13,714 | - | - | Mar 31, 2024 |
STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 2,000 | - | - | Mar 31, 2024 |
Direxion Shares ETF Trust | 0.00% | 50,054 | - | - | Jan 31, 2024 |
Victory Portfolios II | 0.00% | 16,777 | - | - | Mar 31, 2024 |
FIDELITY CONCORD STREET TRUST | 0.00% | 58,533 | - | - | Feb 29, 2024 |
GPS Funds I | 0.00% | 1,357 | - | - | Mar 31, 2024 |
Global X Funds | 0.00% | 10,071 | - | - | Jan 31, 2024 |
AdvisorShares Trust | 0.00% | 795 | - | - | Mar 28, 2024 |
VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 4,286 | - | - | Mar 31, 2024 |
NORTHERN FUNDS | 0.00% | 18,893 | - | - | Mar 28, 2024 |
VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 1,301 | - | - | Mar 31, 2024 |
STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 6,600 | - | - | Mar 31, 2024 |
HC CAPITAL TRUST | 0.00% | 3,000 | - | - | Mar 31, 2024 |
OHIO NATIONAL FUND INC | 0.00% | 1,800 | - | - | Mar 31, 2024 |
RYDEX SERIES FUNDS | 0.00% | 335 | - | - | Dec 31, 2023 |
T. Rowe Price Index Trust, Inc. | 0.00% | 1,518 | - | - | Feb 29, 2024 |
SA FUNDS INVESTMENT TRUST | 0.00% | 1,055 | - | - | Mar 31, 2024 |
ProFunds | 0.00% | 753 | - | - | Mar 31, 2024 |
Blackstone Alternative Investment Funds | 0.00% | 3,900 | - | - | Mar 31, 2023 |
FIDELITY SALEM STREET TRUST | 0.00% | 250,697 | - | - | Mar 31, 2024 |
VANGUARD SCOTTSDALE FUNDS | 0.00% | 121,801 | - | - | Feb 29, 2024 |
RYDEX DYNAMIC FUNDS | 0.00% | 186 | - | - | Dec 31, 2023 |
VALIC Co I | 0.00% | 13,051 | - | - | Feb 29, 2024 |
COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 47,148 | - | - | Mar 31, 2024 |
PGIM ETF TRUST | 0.00% | 2,682 | - | - | Feb 29, 2024 |
PENN SERIES FUNDS INC | 0.00% | 1,100 | - | - | Mar 28, 2024 |
NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 4,696 | - | - | Mar 31, 2024 |
Guggenheim Active Allocation Fund | 0.00% | 209 | - | - | Feb 29, 2024 |
ALLIANZ VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 1,619 | - | - | Dec 31, 2023 |
ALLSPRING FUNDS TRUST | 0.00% | 12,532 | - | - | Jan 31, 2024 |
RYDEX VARIABLE TRUST | 0.00% | 33 | - | - | Dec 31, 2023 |
Goldman Sachs ETF Trust | 0.00% | 2,558 | - | - | Feb 29, 2024 |
TIAA-CREF FUNDS | 0.00% | 79,121 | - | - | Mar 31, 2024 |
Pacer Funds Trust | 0.00% | 923 | - | - | Jan 31, 2024 |
Dimensional ETF Trust | 0.00% | 8,380 | - | - | Jan 31, 2024 |
ALLSPRING MASTER TRUST | 0.00% | 1,112 | - | - | Feb 29, 2024 |
MASTER INVESTMENT PORTFOLIO | 0.00% | 1,505 | - | - | Mar 31, 2024 |
SPDR SERIES TRUST | 0.00% | 639,054 | - | - | Mar 31, 2024 |
USAA MUTUAL FUNDS TRUST | 0.00% | 3,818 | - | - | Jan 31, 2024 |
MORGAN STANLEY PATHWAY FUNDS | 0.00% | 1,619 | - | - | Feb 29, 2024 |
PROSHARES TRUST | 0.00% | 3,581 | - | - | Feb 29, 2024 |
VANGUARD WELLINGTON FUND | 0.00% | 5,547 | - | - | Feb 29, 2024 |
LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 29,800 | - | - | Mar 31, 2024 |
ETF Series Solutions | 0.00% | 240 | - | - | Jan 31, 2024 |
SUNAMERICA SERIES TRUST | 0.00% | 3,883 | - | - | Mar 31, 2024 |
SEI INSTITUTIONAL MANAGED TRUST | 0.00% | 25,930 | - | - | Dec 31, 2023 |
FIRST TRUST EXCHANGE-TRADED FUND | 0.00% | 84 | - | - | Mar 31, 2024 |
DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 8,051 | 8,051 | - | Jan 31, 2024 |
Guggenheim Active Allocation Fund | 0.00% | 41 | - | - | Feb 29, 2024 |
DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 6,052 | - | - | Jan 31, 2024 |
EQ ADVISORS TRUST | 0.00% | 6,893 | - | - | Mar 31, 2024 |
Brighthouse Funds Trust II | 0.00% | 4,364 | - | - | Mar 31, 2024 |
PACIFIC SELECT FUND | 0.00% | 17,398 | - | - | Mar 31, 2024 |
Blackstone Alternative Investment Funds | 0.00% | 500 | - | - | Mar 31, 2024 |
USAA MUTUAL FUNDS TRUST | 0.00% | 763 | - | - | Jan 31, 2024 |
VANGUARD QUANTITATIVE FUNDS | 0.00% | 15 | - | - | Mar 31, 2024 |
MASSMUTUAL SELECT FUNDS | 0.00% | 3,134 | - | - | Dec 31, 2023 |
DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 2,887 | - | - | Jan 31, 2024 |
Invesco Exchange-Traded Fund Trust II | 0.00% | 794 | - | - | Jan 31, 2024 |
Bridge Builder Trust | 0.00% | 10,973 | - | - | Mar 31, 2024 |
AMERICAN CENTURY ETF TRUST | 0.00% | 250 | - | - | Feb 29, 2024 |
BlackRock Variable Series Funds, Inc. | 0.00% | 3,695 | - | - | Mar 31, 2024 |
BLACKROCK FUNDS | 0.00% | 3,552 | - | - | Mar 28, 2024 |
PRINCIPAL FUNDS, INC. | 0.00% | 2,924 | - | - | Feb 29, 2024 |
Advisors' Inner Circle Fund III | 0.00% | 43 | - | - | Jan 31, 2024 |
SEI INSTITUTIONAL INVESTMENTS TRUST | 0.00% | 7,000 | - | - | Feb 29, 2024 |
John Hancock Funds II | 0.00% | 4,313 | - | - | Feb 29, 2024 |
JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 455 | - | - | Mar 31, 2024 |
AIM INVESTMENT FUNDS (INVESCO INVESTMENT FUNDS) | 0.00% | 2,200 | - | - | Jan 31, 2024 |
Neurogene's largest mutual fund holder by % of total assets is "ROYCE MICRO-CAP TRUST, INC.", owning 145.40K shares, compromising 0.30% of its total assets.
Neurogene Institutional Ownership Trends
Institutional Holdings Trend
Date | Holdings | Change % |
---|---|---|
30 Jun, 23 | 37 | - |
31 Mar, 23 | 37 | -19.57% |
31 Dec, 22 | 46 | -4.17% |
30 Sep, 22 | 48 | -17.24% |
30 Jun, 22 | 58 | -27.50% |
31 Mar, 22 | 80 | -2.44% |
31 Dec, 21 | 82 | -2.38% |
30 Sep, 21 | 84 | -2.33% |
30 Jun, 21 | 86 | - |
31 Mar, 21 | 86 | -2.27% |
31 Dec, 20 | 88 | 7.32% |
30 Sep, 20 | 82 | 10.81% |
30 Jun, 20 | 74 | 17.46% |
31 Mar, 20 | 63 | 10.53% |
31 Dec, 19 | 57 | 62.86% |
30 Sep, 19 | 35 | - |
As of 30 Jun 23, 37 institutions are holding Neurogene's shares, representing an increase of 0.00% compared to the previous quarter.
Shares Outstanding Trend
Date | Shares Outstanding | Change % |
---|---|---|
30 Jun, 23 | 17,401,038 | 15.56% |
31 Mar, 23 | 15,057,523 | -11.61% |
31 Dec, 22 | 17,035,708 | -9.00% |
30 Sep, 22 | 18,720,334 | -10.02% |
30 Jun, 22 | 20,804,147 | -15.36% |
31 Mar, 22 | 24,579,324 | -0.30% |
31 Dec, 21 | 24,653,182 | -4.64% |
30 Sep, 21 | 25,853,835 | -4.07% |
30 Jun, 21 | 26,950,324 | -2.98% |
31 Mar, 21 | 27,777,586 | 0.22% |
31 Dec, 20 | 27,716,027 | 0.61% |
30 Sep, 20 | 27,548,615 | 9.66% |
30 Jun, 20 | 25,121,179 | 10.42% |
31 Mar, 20 | 22,749,606 | 16.17% |
31 Dec, 19 | 19,582,953 | 3.94% |
30 Sep, 19 | 18,839,936 | - |
Neurogene (NLTX) has 17.40M shares outstanding as of 30 Jun 23, up 15.56% compared to the previous quarter.
Institutional Ownership Trend
Date | Ownership % | Change % |
---|---|---|
30 Jun, 23 | 31.40% | 4.25% |
31 Mar, 23 | 27.17% | 2.85% |
31 Dec, 22 | 30.85% | 2.69% |
30 Sep, 22 | 33.88% | 2.39% |
30 Jun, 22 | 37.69% | 1.90% |
31 Mar, 22 | 44.57% | 2.22% |
31 Dec, 21 | 44.79% | 2.03% |
30 Sep, 21 | 46.93% | 1.96% |
30 Jun, 21 | 48.98% | 1.92% |
31 Mar, 21 | 50.56% | 1.93% |
31 Dec, 20 | 51.21% | 1.98% |
30 Sep, 20 | 50.90% | 1.97% |
30 Jun, 20 | 50.86% | 2.38% |
31 Mar, 20 | 46.27% | 2.92% |
31 Dec, 19 | 39.83% | 0.77% |
30 Sep, 19 | 71.95% | - |
As of 30 Jun 23, Neurogene is held by 31.40% institutional shareholders, representing a 4.25% growth compared to 31 Mar 23.
Institutional Increased Positions Trend
Date | Increased Positions | Change % |
---|---|---|
30 Jun, 23 | 14 | 40.00% |
31 Mar, 23 | 10 | -33.33% |
31 Dec, 22 | 15 | 36.36% |
30 Sep, 22 | 11 | -54.17% |
30 Jun, 22 | 24 | -36.84% |
31 Mar, 22 | 38 | - |
31 Dec, 21 | 38 | 5.56% |
30 Sep, 21 | 36 | - |
30 Jun, 21 | 36 | 24.14% |
31 Mar, 21 | 29 | -39.58% |
31 Dec, 20 | 48 | -9.43% |
30 Sep, 20 | 53 | 1.92% |
30 Jun, 20 | 52 | 44.44% |
31 Mar, 20 | 36 | -7.69% |
31 Dec, 19 | 39 | 11.43% |
30 Sep, 19 | 35 | - |
14 institutional shareholders have increased their position in NLTX stock as of 30 Jun 23 compared to 10 in the previous quarter (a 40.00% increase).
Institutional Reduced Positions Trend
Date | Reduced Positions | Change % |
---|---|---|
30 Jun, 23 | 8 | -38.46% |
31 Mar, 23 | 13 | -13.33% |
31 Dec, 22 | 15 | -25.00% |
30 Sep, 22 | 20 | -4.76% |
30 Jun, 22 | 21 | -25.00% |
31 Mar, 22 | 28 | 7.69% |
31 Dec, 21 | 26 | -3.70% |
30 Sep, 21 | 27 | 8.00% |
30 Jun, 21 | 25 | -24.24% |
31 Mar, 21 | 33 | 57.14% |
31 Dec, 20 | 21 | 50.00% |
30 Sep, 20 | 14 | 7.69% |
30 Jun, 20 | 13 | - |
31 Mar, 20 | 13 | - |
31 Dec, 19 | 13 | - |
30 Sep, 19 | - | - |
8 institutional shareholders have reduced their position in NLTX stock as of 30 Jun 23 compared to 13 in the previous quarter (a -38.46% decrease).
All Institutional Ownership Trend Data
Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
---|---|---|---|---|---|---|---|---|---|---|
30 Jun, 23 | 37 | - | 17,401,038 | 15.56% | 31.40% | 4.25% | 14 | 40.00% | 8 | -38.46% |
31 Mar, 23 | 37 | -19.57% | 15,057,523 | -11.61% | 27.17% | 2.85% | 10 | -33.33% | 13 | -13.33% |
31 Dec, 22 | 46 | -4.17% | 17,035,708 | -9.00% | 30.85% | 2.69% | 15 | 36.36% | 15 | -25.00% |
30 Sep, 22 | 48 | -17.24% | 18,720,334 | -10.02% | 33.88% | 2.39% | 11 | -54.17% | 20 | -4.76% |
30 Jun, 22 | 58 | -27.50% | 20,804,147 | -15.36% | 37.69% | 1.90% | 24 | -36.84% | 21 | -25.00% |
31 Mar, 22 | 80 | -2.44% | 24,579,324 | -0.30% | 44.57% | 2.22% | 38 | - | 28 | 7.69% |
31 Dec, 21 | 82 | -2.38% | 24,653,182 | -4.64% | 44.79% | 2.03% | 38 | 5.56% | 26 | -3.70% |
30 Sep, 21 | 84 | -2.33% | 25,853,835 | -4.07% | 46.93% | 1.96% | 36 | - | 27 | 8.00% |
30 Jun, 21 | 86 | - | 26,950,324 | -2.98% | 48.98% | 1.92% | 36 | 24.14% | 25 | -24.24% |
31 Mar, 21 | 86 | -2.27% | 27,777,586 | 0.22% | 50.56% | 1.93% | 29 | -39.58% | 33 | 57.14% |
31 Dec, 20 | 88 | 7.32% | 27,716,027 | 0.61% | 51.21% | 1.98% | 48 | -9.43% | 21 | 50.00% |
30 Sep, 20 | 82 | 10.81% | 27,548,615 | 9.66% | 50.90% | 1.97% | 53 | 1.92% | 14 | 7.69% |
30 Jun, 20 | 74 | 17.46% | 25,121,179 | 10.42% | 50.86% | 2.38% | 52 | 44.44% | 13 | - |
31 Mar, 20 | 63 | 10.53% | 22,749,606 | 16.17% | 46.27% | 2.92% | 36 | -7.69% | 13 | - |
31 Dec, 19 | 57 | 62.86% | 19,582,953 | 3.94% | 39.83% | 0.77% | 39 | 11.43% | 13 | - |
30 Sep, 19 | 35 | - | 18,839,936 | - | 71.95% | - | 35 | - | - | - |
Neurogene Insider Shareholders Trades
Open Market Insider Trades
Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
---|
Open Market Insider Buys
Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
---|
Insider Sells
All Insider Owners Trades
The last insider sell of Neurogene's stock was made by Cvijic Christine Mikail on Dec 26 2023, selling - shares at - per share (valued at -).
Neurogene Insider Ownership Trends
All Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q1 2024 | 6 | - | - |
Q4 2023 | 10 | 19 | 52.63% |
Q3 2023 | 13 | 2 | 650.00% |
Q2 2023 | 6 | 1 | 600.00% |
Q1 2023 | 3 | 5 | 60.00% |
Q3 2022 | 6 | 1 | 600.00% |
Q2 2022 | 7 | 1 | 700.00% |
Q1 2022 | 6 | 5 | 120.00% |
Q4 2021 | - | - | - |
Q3 2021 | 7 | - | - |
Q2 2021 | 10 | 14 | 71.43% |
Q1 2021 | 3 | 16 | 18.75% |
Q4 2020 | 1 | - | - |
Q3 2020 | 7 | - | - |
Q2 2020 | 10 | 4 | 250.00% |
Q1 2020 | 7 | 1 | 700.00% |
Q4 2019 | 11 | 3 | 366.67% |
Q3 2019 | 18 | - | - |
Q3 2018 | 4 | - | - |
Q2 2018 | 7 | 2 | 350.00% |
6 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Neurogene's insiders, as of Q1 2024.
Open Market Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q1 2024 | - | - | - |
Q4 2023 | - | - | - |
Q3 2023 | 12 | 1 | 1200.00% |
Q2 2023 | - | 1 | - |
Q1 2023 | - | 2 | - |
Q3 2022 | - | 1 | - |
Q2 2022 | - | 1 | - |
Q1 2022 | - | - | - |
Q4 2021 | - | - | - |
Q3 2021 | 2 | - | - |
Q2 2021 | 2 | 14 | 14.29% |
Q1 2021 | - | 13 | - |
Q4 2020 | - | - | - |
Q3 2020 | 4 | - | - |
Q2 2020 | 4 | 4 | 100.00% |
Q1 2020 | 5 | - | - |
Q4 2019 | 3 | - | - |
Q3 2019 | 13 | - | - |
Q3 2018 | - | - | - |
Q2 2018 | - | 1 | - |
As of Q1 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Neurogene's stocks.
NLTX Ownership FAQ
Who Owns Neurogene?
Neurogene is owned by institutional shareholders (31.40%), insiders (16.46%), and public (52.14%). The largest institutional shareholder of Neurogene is US BANCORP \DE\ (0% of total shares) and the top mutual fund owner is ROYCE MICRO-CAP TRUST, INC. (0.30% of total shares).
Who are the major institutional shareholders of Neurogene?
Neurogene's major institutional shareholders are US BANCORP \DE\, WELLS FARGO & COMPANY/MN, NORTHERN TRUST CORP, MORGAN STANLEY, and NATIONAL BANK OF CANADA /FI/. The top five shareholders own together 0% of the company's share outstanding.
How many Neurogene shareholders are there?
As of Jun 2023, there are 37 institutional shareholders of Neurogene.
What percentage of Neurogene is owned by US BANCORP \DE\?
US BANCORP \DE\ owns 0 shares of Neurogene, representing 0% of the company's total shares outstanding, valued at $0 (as of Sep 2023).
What percentage of Neurogene is owned by WELLS FARGO & COMPANY/MN?
As of Sep 2023, WELLS FARGO & COMPANY/MN holds 0 shares of Neurogene (NLTX), compromising 0% of the company, valued at $0.
What percentage of Neurogene is owned by NORTHERN TRUST CORP?
NORTHERN TRUST CORP is the third largest holder of Neurogene. The company owns 0 of the company's shares outstanding (worth $0).